Skip to main content

Merck announces ADC/HPAPI expansion

Merck KGaA is to spend €59 million to expand HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin. Completion is expected by mid-2022 and should add approximately 50 full-time jobs from 2021.

The investment will allow large-scale manufacturing of highly potent oncology compounds, the company said. The 6,500 m2 building will be one of the largest dedicated HPAPI facilities specifically designed to handle single-digit nanogram OEL materials.

Azelis to distribute for Merck in Vietnam

Azelis has concluded a new agreement with Merck KGaA, covering the distribution of Merck Performance Materials’ complete range in Vietnam for personal care, CASE, food and health, and industrial chemicals. The division’s products include pigments, active ingredients and raw materials. The two companies have been partners since 1968 and have existing distribution relationships in Europe and other regions.

Pigments exit for Merck?

According to a story given by company insiders to the news agency Bloomberg, Merck KGaA is considering the sale of its Effect Pigments business.

Merck to spend €1 billion more at Darmstadt

The management and joint works council of Merck KGaA have made a comprehensive agreement about the main site in Darmstadt, Germany, with the stated aim of securing its future viability as a central science and technology hub and further expanding it.
Subscribe to Merck

 

 

 

AMRI banner advert